An observational study in Acute Disease, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to participants aged 80 Years and older. Per ClinicalTrials.gov, last updated 2012-01-09.
Sponsored by University of Aarhus · Observational
The purpose of this study is to compare acute ill elderly medical patients in a geriatric department with general medical departments, and to examine the effects of comprehensive geriatric assessment in the geriatric setting compared with general medical care.
Design:
285 studies on the registry are indexed under Acute Disease; 39 are open to participants now.
This study's enrollment of 3,877 is above the median of 200 across 83 observational studies indexed under Acute Disease.
Browse Acute Disease studies →University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Acute medical patients aged 80 years or older
Exclusion Criteria:
The patients receive comprehensive geriatric assessment
This group do not receive comprehensive geriatric assessment
Comorbidity
By Charlsons Comorbidity Index
Time frame: At hospital admission (day 1)
Length of hospital stay
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
Time frame: Number of days of hospitalization an expected average of 8 days
Acute readmission
The number of acute readmissions in the participants within 30 days and 90 days after the discharge, respectively.
Time frame: 30 days and 90 days
Mortality
The number of short-term mortality in the participants within 30 days after hospital admission.
Time frame: Within 30 days after hospital admission
This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aarhus